Authors
Loading...
This study demonstrates SOX4 downregulates PTEN via miR-106b~25 in prostate cancer, suggesting new therapeutic targets.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: